Clinical Trial

Comparison of the Efficacy of Celiac Plexus Blockade, ESP and Lidocaine Infusion Under OFA

Study acronym: LECO
Recruiting
View on ClinicalTrials.gov →
Summary
Modern anesthesiology, in search of alternatives to opioid-based pain management, is turning to low-opioid and non-opioid protocols. Replacing opioids with non-opioid analgesics, co-analgesics, and regional and local anesthesia techniques allows avoiding the adverse effects of opioids while maintaining satisfactory analgesia. This is of particular importance in bariatric surgery, where reducing the incidence of respiratory depression, sedation, opioid hyperalgesia, and postoperative nausea and vomiting is a priority. Standard non-opioid anesthesia (OFA) includes ketamine, lidocaine, and dexmedetomidine infusions, while regional techniques additionally reduce the need for analgesics. Despite the widespread use of these methods, there is no clear data on the superiority of any of them in bariatric procedures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-21.
Status change: Not Yet Recruiting → Recruiting 2025-04-02
Trial Details
NCT Number NCT06793527
Lead Sponsor Jagiellonian University
Conditions Regional Anaesthesia, Anesthesia and Analgesia
Enrollment 300 participants
Start Date 2025-02-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-04